ELEVANCE HEALTH INC (ELV) Stock Fundamental Analysis
USA - NYSE:ELV - US0367521038 - Common Stock
325.83 USD
-2.45 (-0.75%)
325.83 USD
0 (0%)
Overall ELV gets a fundamental rating of 4 out of 10. We evaluated ELV against 100 industry peers in the Health Care Providers & Services industry. ELV has a medium profitability rating, but doesn't score so well on its financial health evaluation. ELV has a decent growth rate and is not valued too expensively. Finally ELV also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
ELV had positive earnings in the past year.
ELV had a positive operating cash flow in the past year.
ELV had positive earnings in each of the past 5 years.
In the past 5 years ELV always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 4.51%, ELV is in the better half of the industry, outperforming 73.00% of the companies in the same industry.
With a decent Return On Equity value of 12.59%, ELV is doing good in the industry, outperforming 76.00% of the companies in the same industry.
The Return On Invested Capital of ELV (5.60%) is comparable to the rest of the industry.
ELV had an Average Return On Invested Capital over the past 3 years of 6.90%. This is below the industry average of 9.45%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.51% | ||
| ROE | 12.59% | ||
| ROIC | 5.6% |
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
1.3 Margins
The Profit Margin of ELV (2.84%) is better than 65.00% of its industry peers.
ELV's Profit Margin has declined in the last couple of years.
ELV has a Operating Margin of 4.35%. This is comparable to the rest of the industry: ELV outperforms 58.00% of its industry peers.
ELV's Operating Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.35% | ||
| PM (TTM) | 2.84% | ||
| GM | N/A |
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ELV is destroying value.
Compared to 1 year ago, ELV has less shares outstanding
ELV has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, ELV has a worse debt to assets ratio.
2.2 Solvency
The Debt to FCF ratio of ELV is 8.63, which is on the high side as it means it would take ELV, 8.63 years of fcf income to pay off all of its debts.
ELV has a Debt to FCF ratio (8.63) which is comparable to the rest of the industry.
ELV has a Debt/Equity ratio of 0.71. This is a neutral value indicating ELV is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.71, ELV is in line with its industry, outperforming 51.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 8.63 | ||
| Altman-Z | N/A |
ROIC/WACC0.65
WACC8.6%
2.3 Liquidity
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | N/A | ||
| Quick Ratio | N/A |
3. Growth
3.1 Past
ELV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.71%.
Measured over the past years, ELV shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.17% on average per year.
ELV shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.96%.
Measured over the past years, ELV shows a quite strong growth in Revenue. The Revenue has been growing by 11.14% on average per year.
EPS 1Y (TTM)-11.71%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-27.96%
Revenue 1Y (TTM)11.96%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%12%
3.2 Future
Based on estimates for the next years, ELV will show a small growth in Earnings Per Share. The EPS will grow by 7.78% on average per year.
Based on estimates for the next years, ELV will show a small growth in Revenue. The Revenue will grow by 4.62% on average per year.
EPS Next Y-8.18%
EPS Next 2Y-8.53%
EPS Next 3Y-1.23%
EPS Next 5Y7.78%
Revenue Next Year13.06%
Revenue Next 2Y8.03%
Revenue Next 3Y7.01%
Revenue Next 5Y4.62%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 10.62, the valuation of ELV can be described as very reasonable.
90.00% of the companies in the same industry are more expensive than ELV, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 25.89. ELV is valued rather cheaply when compared to this.
ELV is valuated reasonably with a Price/Forward Earnings ratio of 11.81.
83.00% of the companies in the same industry are more expensive than ELV, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.59, ELV is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.62 | ||
| Fwd PE | 11.81 |
4.2 Price Multiples
74.00% of the companies in the same industry are more expensive than ELV, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ELV indicates a somewhat cheap valuation: ELV is cheaper than 65.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.72 | ||
| EV/EBITDA | 9.7 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)0.95
EPS Next 2Y-8.53%
EPS Next 3Y-1.23%
5. Dividend
5.1 Amount
ELV has a Yearly Dividend Yield of 2.18%.
Compared to an average industry Dividend Yield of 2.55, ELV pays a better dividend. On top of this ELV pays more dividend than 91.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, ELV has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.18% |
5.2 History
On average, the dividend of ELV grows each year by 15.34%, which is quite nice.
ELV has been paying a dividend for at least 10 years, so it has a reliable track record.
ELV has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)15.34%
Div Incr Years13
Div Non Decr Years13
5.3 Sustainability
ELV pays out 27.56% of its income as dividend. This is a sustainable payout ratio.
The dividend of ELV is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP27.56%
EPS Next 2Y-8.53%
EPS Next 3Y-1.23%
325.83
-2.45 (-0.75%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners93.05%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner Change3.2%
Market Cap73.37B
Revenue(TTM)194.82B
Net Income(TTM)5.53B
Analysts75.17
Price Target393.88 (20.89%)
Short Float %1.22%
Short Ratio1.36
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.18% |
Yearly Dividend6.55
Dividend Growth(5Y)15.34%
DP27.56%
Div Incr Years13
Div Non Decr Years13
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.38%
Min EPS beat(2)-2.26%
Max EPS beat(2)21.02%
EPS beat(4)3
Avg EPS beat(4)5.76%
Min EPS beat(4)-2.26%
Max EPS beat(4)21.02%
EPS beat(8)5
Avg EPS beat(8)0.95%
EPS beat(12)8
Avg EPS beat(12)1.31%
EPS beat(16)11
Avg EPS beat(16)1.68%
Revenue beat(2)2
Avg Revenue beat(2)0.95%
Min Revenue beat(2)0.45%
Max Revenue beat(2)1.45%
Revenue beat(4)3
Avg Revenue beat(4)1.37%
Min Revenue beat(4)-0.71%
Max Revenue beat(4)4.3%
Revenue beat(8)4
Avg Revenue beat(8)0.64%
Revenue beat(12)6
Avg Revenue beat(12)0.78%
Revenue beat(16)9
Avg Revenue beat(16)0.69%
PT rev (1m)5.44%
PT rev (3m)2.54%
EPS NQ rev (1m)-22.59%
EPS NQ rev (3m)-22.39%
EPS NY rev (1m)0.27%
EPS NY rev (3m)-12.87%
Revenue NQ rev (1m)0.41%
Revenue NQ rev (3m)0.75%
Revenue NY rev (1m)0.65%
Revenue NY rev (3m)0.79%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.62 | ||
| Fwd PE | 11.81 | ||
| P/S | 0.38 | ||
| P/FCF | 19.72 | ||
| P/OCF | 15.08 | ||
| P/B | 1.67 | ||
| P/tB | 17.57 | ||
| EV/EBITDA | 9.7 |
EPS(TTM)30.68
EY9.42%
EPS(NY)27.58
Fwd EY8.47%
FCF(TTM)16.52
FCFY5.07%
OCF(TTM)21.61
OCFY6.63%
SpS865.17
BVpS195.19
TBVpS18.54
PEG (NY)N/A
PEG (5Y)0.95
Graham Number367.07
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.51% | ||
| ROE | 12.59% | ||
| ROCE | 7.32% | ||
| ROIC | 5.6% | ||
| ROICexc | 6.06% | ||
| ROICexgc | 10.93% | ||
| OM | 4.35% | ||
| PM (TTM) | 2.84% | ||
| GM | N/A | ||
| FCFM | 1.91% |
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
ROICexc(3y)7.45%
ROICexc(5y)7.72%
ROICexgc(3y)13.9%
ROICexgc(5y)14.63%
ROCE(3y)9.03%
ROCE(5y)9.4%
ROICexgc growth 3Y-5.49%
ROICexgc growth 5Y-3.16%
ROICexc growth 3Y-5.02%
ROICexc growth 5Y-2.23%
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.59
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 8.63 | ||
| Debt/EBITDA | 3.13 | ||
| Cap/Depr | 74.45% | ||
| Cap/Sales | 0.59% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 48.59% | ||
| Profit Quality | 67.25% | ||
| Current Ratio | N/A | ||
| Quick Ratio | N/A | ||
| Altman-Z | N/A |
F-Score4
WACC8.6%
ROIC/WACC0.65
Cap/Depr(3y)77.74%
Cap/Depr(5y)81.03%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.76%
Profit Quality(3y)103.66%
Profit Quality(5y)128.32%
High Growth Momentum
Growth
EPS 1Y (TTM)-11.71%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-27.96%
EPS Next Y-8.18%
EPS Next 2Y-8.53%
EPS Next 3Y-1.23%
EPS Next 5Y7.78%
Revenue 1Y (TTM)11.96%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%12%
Revenue Next Year13.06%
Revenue Next 2Y8.03%
Revenue Next 3Y7.01%
Revenue Next 5Y4.62%
EBIT growth 1Y-10.69%
EBIT growth 3Y0%
EBIT growth 5Y6.19%
EBIT Next Year-1.57%
EBIT Next 3Y2.35%
EBIT Next 5Y8.31%
FCF growth 1Y-54.88%
FCF growth 3Y-14.89%
FCF growth 5Y-2.08%
OCF growth 1Y-48.85%
OCF growth 3Y-11.78%
OCF growth 5Y-1.08%
ELEVANCE HEALTH INC / ELV FAQ
Can you provide the ChartMill fundamental rating for ELEVANCE HEALTH INC?
ChartMill assigns a fundamental rating of 4 / 10 to ELV.
What is the valuation status for ELV stock?
ChartMill assigns a valuation rating of 6 / 10 to ELEVANCE HEALTH INC (ELV). This can be considered as Fairly Valued.
What is the profitability of ELV stock?
ELEVANCE HEALTH INC (ELV) has a profitability rating of 4 / 10.
Can you provide the expected EPS growth for ELV stock?
The Earnings per Share (EPS) of ELEVANCE HEALTH INC (ELV) is expected to decline by -8.18% in the next year.
Is the dividend of ELEVANCE HEALTH INC sustainable?
The dividend rating of ELEVANCE HEALTH INC (ELV) is 7 / 10 and the dividend payout ratio is 27.56%.